No Data
No Data
Jiuyuan Yinhai (002777): The medical insurance business maintains high growth and the data element business is being implemented at an accelerated pace
Investment events: Recently, the company released its 2023 annual report and 2024 quarterly report: (1) 2023 operating income of 1,347 billion yuan, up 5.01% year on year; net profit to mother 168 million yuan, down 8.8 million year on year
Jiuyuan Yinhai (002777.SZ) announced first-quarter results. Net profit of 13.433,500 yuan decreased 19.8% year over year
Jiuyuan Yinhai (002777.SZ) released its report for the first quarter of 2024. The company achieved operating income of 1 during the reporting period...
Jiuyuan Yinhai (002777) 2023 Annual Report Review: Achieving Steady Growth in Revenue and Expanding the Future of Research and Development
Event: The company released the “2023 Annual Report” after the close of trading on April 2, 2024. Comment: Operating income achieved steady growth, and net cash flow from operating activities improved significantly compared to 2023. The company continued
Guoyuan Securities released a research report on April 10 stating that it gave Jiuyuan Yinhai (002777.SZ) a purchase rating. The main reasons for the rating include: 1) achieving steady growth in operating income and a significant improvement in net cash
Guoyuan Securities released a research report on April 10 stating that it gave Jiuyuan Yinhai (002777.SZ) a purchase rating. The main reasons for the rating include: 1) achieving steady growth in operating income and a significant improvement in net cash flow from operating activities; 2) continuing to explore various application scenarios for innovative health insurance data elements to actively expand smart city business; 3) continuing to increase investment in R&D and launch a large-scale model in the field of people's livelihood that Yinhai is famous for. (Mainichi Keizai Shimbun)
The DRG concept fluctuated and fell. Rongke Technology fell more than 8%, followed by Jiuyuan Yinhai, Entrepreneurship Huikang, Sichuang Medicare, Guoxin Health, and Shandai Latitude.
The DRG concept fluctuated and fell. Rongke Technology fell more than 8%, followed by Jiuyuan Yinhai, Entrepreneurship Huikang, Sichuang Medicare, Guoxin Health, and Shandai Latitude.
Jiuyuan Yinhai (002777): Health Insurance Data Element Pioneer Towards High Quality Growth
Revenue grew steadily, and cash flow improved year over year. The company discloses its 2023 annual report. In 2023, the company achieved revenue of 1,347 billion yuan, a year-on-year increase of 5.01%; net profit to mother was 168 million yuan, a year-on-year decrease of 8.83 million yuan
No Data